NO172185C - Fremgangsmaate for fremstilling av glukagon - Google Patents
Fremgangsmaate for fremstilling av glukagonInfo
- Publication number
- NO172185C NO172185C NO860178A NO860178A NO172185C NO 172185 C NO172185 C NO 172185C NO 860178 A NO860178 A NO 860178A NO 860178 A NO860178 A NO 860178A NO 172185 C NO172185 C NO 172185C
- Authority
- NO
- Norway
- Prior art keywords
- glucagon
- derivatives
- expression
- yeast
- fragments
- Prior art date
Links
- 102000051325 Glucagon Human genes 0.000 title abstract 4
- 108060003199 Glucagon Proteins 0.000 title abstract 4
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title abstract 4
- 229960004666 glucagon Drugs 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 108700005078 Synthetic Genes Proteins 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/30—Signal or leader sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK27885A DK27885A (da) | 1985-01-22 | 1985-01-22 | Fremstilling af peptider |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO860178L NO860178L (no) | 1986-07-23 |
| NO172185B NO172185B (no) | 1993-03-08 |
| NO172185C true NO172185C (no) | 1993-06-16 |
Family
ID=8091749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860178A NO172185C (no) | 1985-01-22 | 1986-01-20 | Fremgangsmaate for fremstilling av glukagon |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4826763A (da) |
| EP (1) | EP0189998B1 (da) |
| JP (2) | JPH0720435B2 (da) |
| AT (1) | ATE48643T1 (da) |
| AU (1) | AU587218B2 (da) |
| CA (1) | CA1294232C (da) |
| DE (1) | DE3667488D1 (da) |
| DK (1) | DK27885A (da) |
| ES (1) | ES8708250A1 (da) |
| FI (1) | FI87800C (da) |
| GR (1) | GR860149B (da) |
| IE (1) | IE58726B1 (da) |
| MX (1) | MX163776B (da) |
| NO (1) | NO172185C (da) |
| NZ (1) | NZ214883A (da) |
| PT (1) | PT81872B (da) |
| ZA (1) | ZA86393B (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5151354A (en) * | 1986-08-21 | 1992-09-29 | Cornelius Hollenberg | Fermentation processes using amylolytic enzyme producing microorganisms |
| ATE121776T1 (de) * | 1986-09-19 | 1995-05-15 | Zymogenetics Inc | Expression des biologisch aktiven faktors xiii. |
| JPH01187499A (ja) * | 1988-01-21 | 1989-07-26 | Science & Tech Agency | 原子炉解体用ロボット |
| IL93173A0 (en) * | 1989-02-01 | 1990-11-05 | Shionogi & Co | Production of glucagon |
| US6172039B1 (en) | 1990-04-16 | 2001-01-09 | Apex Bioscience, Inc. | Expression of recombinant hemoglobin and hemoglobin variants in yeast |
| US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
| US5408037A (en) * | 1991-01-17 | 1995-04-18 | Zymogenetics, Inc. | Methods for detecting glucagon antagonists |
| US5510459A (en) * | 1991-01-17 | 1996-04-23 | Zymogenetics, Inc. | Glucagon antagonists |
| DE69302692T2 (de) * | 1992-07-06 | 1996-10-02 | Beckman Instruments Inc | Flüssigkeitsversorgungssystem mit Mehrwegventil |
| DK144093D0 (da) * | 1993-12-23 | 1993-12-23 | Novo Nordisk As | |
| US5652216A (en) * | 1994-05-26 | 1997-07-29 | Novo Nordisk A/S | Pharmaceutical preparation |
| CN1264307B (zh) * | 1997-05-16 | 2013-10-30 | 1149336安大略公司 | 改善上胃肠道功能的方法 |
| US7655618B2 (en) | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| JP2006514990A (ja) * | 2002-12-27 | 2006-05-18 | ディオベックス， インコーポレイテッド | インスリン誘発性低血糖の予防および制御のための組成物および方法 |
| BR122021021381B1 (pt) | 2009-02-03 | 2023-05-16 | Amunix Pharmaceuticals, Inc | Método de aprimoramento de uma propriedade de uma proteína biologicamente ativa |
| DK2440228T3 (da) | 2009-06-08 | 2018-12-17 | Amunix Operating Inc | Glucoseregulerende polypeptider og fremgangsmåder til fremstilling og anvendelse deraf |
| CN104302408B (zh) | 2012-02-27 | 2016-12-14 | 阿穆尼克斯运营公司 | Xten缀合组合物和制造其的方法 |
| WO2020074583A1 (en) | 2018-10-09 | 2020-04-16 | Fresenius Kabi Ipsum S.R.L. | Process for the manufacture of glp-1 analogues |
| EP3753946A1 (en) | 2019-06-18 | 2020-12-23 | Fresenius Kabi iPSUM S.r.l. | Improved process for the preparation of high purity glucagon |
| CN114401981B (zh) | 2019-06-18 | 2024-11-08 | 北京费森尤斯卡比医药有限公司 | 胰高血糖素制造方法 |
| AU2020382621A1 (en) | 2019-11-13 | 2022-06-02 | Amunix Pharmaceuticals, Inc. | Barcoded XTEN polypeptides and compositions thereof, and methods for making and using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4401759A (en) * | 1980-05-01 | 1983-08-30 | Harvey Rubin | Detection and isolation of glucagon mRNA using a synthetic oligodeoxynucleotide |
| DK283180A (da) * | 1980-07-01 | 1982-01-02 | Novo Industri As | Polypeptider og derivater deraf |
| US4546082A (en) * | 1982-06-17 | 1985-10-08 | Regents Of The Univ. Of California | E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins |
-
1985
- 1985-01-22 DK DK27885A patent/DK27885A/da unknown
-
1986
- 1986-01-20 MX MX1277A patent/MX163776B/es unknown
- 1986-01-20 GR GR860149A patent/GR860149B/el active IP Right Revival
- 1986-01-20 ZA ZA86393A patent/ZA86393B/xx unknown
- 1986-01-20 FI FI860251A patent/FI87800C/fi not_active IP Right Cessation
- 1986-01-20 PT PT81872A patent/PT81872B/pt active IP Right Revival
- 1986-01-20 ES ES551042A patent/ES8708250A1/es not_active Expired
- 1986-01-20 AU AU52472/86A patent/AU587218B2/en not_active Expired
- 1986-01-20 DE DE8686300384T patent/DE3667488D1/de not_active Expired - Lifetime
- 1986-01-20 AT AT86300384T patent/ATE48643T1/de not_active IP Right Cessation
- 1986-01-20 NO NO860178A patent/NO172185C/no not_active IP Right Cessation
- 1986-01-20 IE IE16286A patent/IE58726B1/en not_active IP Right Cessation
- 1986-01-20 JP JP61009822A patent/JPH0720435B2/ja not_active Expired - Lifetime
- 1986-01-20 EP EP86300384A patent/EP0189998B1/en not_active Expired
- 1986-01-20 CA CA000499911A patent/CA1294232C/en not_active Expired - Lifetime
- 1986-01-21 NZ NZ214883A patent/NZ214883A/en unknown
- 1986-01-21 US US06/820,144 patent/US4826763A/en not_active Expired - Lifetime
-
1993
- 1993-10-13 JP JP5255433A patent/JPH0746986B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI860251L (fi) | 1986-07-23 |
| FI860251A0 (fi) | 1986-01-20 |
| DE3667488D1 (de) | 1990-01-18 |
| ES551042A0 (es) | 1987-10-01 |
| IE58726B1 (en) | 1993-11-03 |
| JPH0720435B2 (ja) | 1995-03-08 |
| ATE48643T1 (de) | 1989-12-15 |
| EP0189998B1 (en) | 1989-12-13 |
| JPH0746986B2 (ja) | 1995-05-24 |
| FI87800C (fi) | 1993-02-25 |
| ZA86393B (en) | 1987-03-25 |
| NZ214883A (en) | 1988-04-29 |
| GR860149B (en) | 1986-05-21 |
| JPH06292594A (ja) | 1994-10-21 |
| PT81872A (en) | 1986-02-01 |
| IE860162L (en) | 1986-07-22 |
| US4826763A (en) | 1989-05-02 |
| AU5247286A (en) | 1986-07-31 |
| JPS61181398A (ja) | 1986-08-14 |
| NO860178L (no) | 1986-07-23 |
| NO172185B (no) | 1993-03-08 |
| FI87800B (fi) | 1992-11-13 |
| DK27885D0 (da) | 1985-01-22 |
| AU587218B2 (en) | 1989-08-10 |
| PT81872B (pt) | 1988-05-27 |
| ES8708250A1 (es) | 1987-10-01 |
| CA1294232C (en) | 1992-01-14 |
| EP0189998A1 (en) | 1986-08-06 |
| DK27885A (da) | 1986-07-23 |
| MX163776B (es) | 1992-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO172185C (no) | Fremgangsmaate for fremstilling av glukagon | |
| AU2790292A (en) | Viral recombinant vectors for expression in muscle cells | |
| BG47033A3 (en) | Method for preparing of derivatives of imidazolamine | |
| AU573768B2 (en) | Hyaluronic acid from streptococci | |
| GR3035627T3 (en) | A mammalian cytokine, il-11. | |
| AU4833897A (en) | Glial mitogenic factors, their preparation and use | |
| EP0853121A3 (en) | Human DNase | |
| NO871785D0 (no) | Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse. | |
| AU6733487A (en) | Mammalian interleukin-4 | |
| DE3855523D1 (de) | Proteine mit Faktor-VIII-Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende pharmazeutische Zusammensetzungen | |
| IL68366A (en) | Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture | |
| IE840258L (en) | Expression of gene products. | |
| IL75963A0 (en) | Interferon derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3888459D1 (de) | Zellzüchtung in kontinuierlicher Dispersionskultur mit einem System zur Gewinnung von Zellprodukten. | |
| AU1987088A (en) | A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation | |
| EP0363127A3 (en) | Improvements in or relating to eukaryotic expression | |
| AU2430588A (en) | Mutant acidic fibroblast growth factor | |
| AU7265087A (en) | Animal cell transformant, method for obtaining the transformant and method for producing desired foreign gene product by using the transformant | |
| AU6286086A (en) | An improved heat-shock control method and system for the production of competent eukaryotic gene products | |
| EP0343388A3 (en) | Expression of interferon-gamma in methylotrophic yeasts | |
| IT8521507A0 (it) | Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni. | |
| EP0165759A3 (en) | Mammalian promotors useful in yeast expression | |
| WU | SYNTHESIS AND SECRETION OF HUMAN IFN-? B IN SACCHAROMYCE CEREVISIAE | |
| UA5743C2 (uk) | Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання | |
| DK28386A (da) | Fremstilling af peptider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |